Our lab aims to develop novel magnetic resonance
imaging (MRI)-based methods for characterizing tumor
microenvironment properties (acidosis, vascularization, hypoxia) in
murine tumor models. We are interested in developing
and validating non-invasive MRI procedures and probes for
improving diagnosis and assessment of treatment effects with
a special focus on tumor metabolism and on antiangiogenic
drugs. Our studies also focus on assessing pH imaging
as a novel biomarker in cancer and in renal diseases.
Our lab bridges theoretical and experimental aspects of
biological research, combining chemistry, biology and
medicine with in vitro and in vivo preclinical studies.


Dario Longo, PhD
Head, Research Unit of Torino
Institute of Biostructures
and Bioimaging (IBB)
Italian National Research Council
(CNR)
Via Nizza, 52
10126 Torino - Italy
Tel: +39 011 6706473
Fax: +39 011 6706458
dariolivio.longo@cnr.it
dario.longo@unito.it
Developing MRI-based probes

Imaging Tumor Acidosis

MRI-CEST RENAL pH IMAGING

Imaging Tumor Angiogenesis

Upcoming Events
NEWS
- New research article on a novel multislice sequence for 3D MRI-CEST pH imaging published in Magnetic Resonance in Medicine 2021; 85:1335-1349.
- New research article on a combined approach for evaluating renal perfusion and pH published in NRM in Biomedicine, 2020, 33, e4287.
- New research article on a novel melanin-based probe for optoacoustic imaging published in Applied Sciences 2020, 10, 8313.
- New review focussing on imaging tumor metabolism published in Frontiers in Oncology, 2020, 10, 161
- New review focussing on imaging tumor acidosis published in Cancer Metastasis Review 2019; 38:25-49
New book chapter in CEST imaging: "Iodinated Contrast Media as pH-Responsive CEST Agents" In: Chemical Exchange Saturation Transfer Imaging: Advances and Applications.